Ultrasound-Guided Carpal Tunnel Infiltration: Comparison Between the Manual Method and a Robot-Assisted Method

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorCentre Hospitalier Régional d'Orléans

About this trial

This study aims to assess the feasibility, safety, and accuracy of a robotic arm-assisted carpal tunnel injection in comparison with the conventional ultrasound-guided method, prior to conducting a larger-scale study.

The use of a robotic arm to maintain the ultrasound probe in position could provide valuable assistance to the physician. The procedure would no longer require the involvement of a third person in addition to the physician. To date, no study has compared these two approaches.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 and ≤ 75 years.

Clinical diagnosis of carpal tunnel syndrome.

Indication for corticosteroid injection as determined by investigator.

Moderate to severe carpal tunnel syndrome defined by a pain score on the Visual Analogue Scale (VAS) ≥ 4 (at baseline and on day 0).

Disqualifiers

Known allergy to corticosteroids or povidone-iodine (Betadine)

Probable or ongoing systemic or local infection

History of injection in the affected wrist within the last 6 months

Thenar eminence atrophy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Carpal tunnel injection

    Procedure/Surgery

    Ultrasound localization will be performed by the physician. He will then perform the injection under ultrasound guidance. In Group A, maintenance of the ultrasound probe during the injection will be performed by the physician assisted by a nurse. In Group B, maintenance of the ultrasound probe during the injection will be performed by the robotic arm. All other aspects of the procedure will be carried out according to usual standards (localization, aseptic technique, injection, etc…). The procedure will be timed from the initial positioning (first contact of the ultrasound probe with the wrist) to the end of the injection (needle withdrawal). Maintenance of participant blinding during the injection: a drape will be placed between the physician and the participant; the robot will be activated in both groups, the participant will wear anti noise headphones, and a nurse will be present in both groups.

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: Manual (Arm A)Active comparator 1 intervention
Group B: Robot-Assisted (Arm B)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Comparison of the variation of the VAS scale on the Ultrasound-Guided Carpal Tunnel Injection between the Manual Method and a Robot-Assisted Method

VAS: Scale 1 to 10 with 1 is no pain at all and 10 is the worst pain that the participant can imagine.

Time frame
This outcome is measured on the day of the intervention (Day 0) after randomization and a month after the intervention (Day 28)

Secondary outcomes

1

Pain VAS at D7 and 3 months

VAS: Scale 1 to 10 with 1 is no pain at all and 10 is the worst pain that the participant can imagine.

Time frame
This outcome is measured on Day 0 (D0) after randomization, Day 7 (D7), Day 28 (D28), and Month 3 (M3)
2

Compare the evolution of the BCTQ (Boston Carpal Tunnel Questionnaire, subscale SSS) score over time according to the method (Arm A versus Arm B)

Compare the evolution of the Symptom Severity Scale (SSS) score, subscale 1 of BCTQ score. This subscale, the minimum is 11 points (no symptoms) and the maximum is 55 points (maximum severity of symptoms).

Time frame
This outcome is measured on Day 0 (D0) after randomization, Day 7 (D7), Day 28 (D28), and Month 3 (M3)
3

Compare the evolution of the BCTQ (Boston Carpal Tunnel Questionnaire, subscale FSS) score over time according to the method (Arm A versus Arm B)

Compare the evolution of the Functional Status Scale (FSS) score, subscale 2 of BCTQ score. This subscale, the minimum is 8 points (no functional difficulty) and the maximum is 40 points (maximum functional difficulties).

Time frame
This outcome is measured on Day 0 (D0) after randomization, Day 7 (D7), Day 28 (D28), and Month 3 (M3)
4

Compare the duration of the procedure according to the method (Arm A versus Arm B)

Procedure duration, in minutes, measured between initial positioning (first contact of the ultrasound probe with the wrist) and completion of the injection (needle withdrawal).

Time frame
This outcome is measured on Day 0 (D0) after randomization

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.